Scientific advisors and collaborators
In order to strengthen Alligator’s research programs, the company collaborates with leading experts within relevant fields of research. Alligator currently works with the following partners and scientific advisors:
Professor Ignacio Melero
Professor Ignacio Melero, University of Navarra, Spain is an expert in immunotherapy for cancer. Professor Melero´s research focuses on translational studies of e.g. the TNF receptor superfamily and clinical development of immunotherapeutic drugs.
Professor Jeffrey Weber
Professor Jeffrey Weber, Perlmutter Cancer Center at Langone Medical Center, New York, , USA, is an expert in clinical immuno-oncology. Professor Weber has led several clinical studies of e.g. CTLA-4 and PD-1 blocking antibodies and is one of the pioneers in management of autoimmune adverse events induced by immunotherapies. With his extensive expertise in clinical development of immunotherapies, he is a key discussion partner for Alligator regarding clinical studies.
Professor Thomas Tötterman
Professor Thomas Tötterman, Uppsala University, Sweden, is a pioneer in cancer immunotherapy, in particular relating to intratumoral injections of CD40 activating immunotherapies.
Professor Peter Stern
Professor Peter Stern, University of Manchester, United Kingdom, is an expert in tumor-associated antigens and virus-associated tumors. Professor Stern´s research has contributed greatly to the development of both cancer vaccines and antibody-based drugs for cancer treatment.
Doktor Holbrook Kohrt, Stanford University, USA, was one of the pioneers in immuno-oncology until passing away in 2016. He has been an important discussion partner for the Company in the development of ATOR-1015. The collaboration with Stanford University is still ongoing.